| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1047582122 |
| P356 | DOI | 10.1038/71673 |
| P698 | PubMed publication ID | 10615126 |
| P5875 | ResearchGate publication ID | 51360894 |
| P2093 | author name string | Ohashi K | |
| Naldini L | |||
| Chiu W | |||
| Kay MA | |||
| Park F | |||
| P2860 | cites work | Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors | Q45884182 |
| Intramuscular injection of an adenoviral vector expressing hepatocyte growth factor facilitates hepatic transduction with a retroviral vector in mice | Q64381551 | ||
| Factors influencing retroviral-mediated gene transfer into hepatocytes in vivo | Q72858896 | ||
| Hepatocyte growth factor induces hepatocyte proliferation in vivo and allows for efficient retroviral-mediated gene transfer in mice | Q77220644 | ||
| HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure | Q28283258 | ||
| In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector | Q29547503 | ||
| A third-generation lentivirus vector with a conditional packaging system | Q29616120 | ||
| Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo | Q29616612 | ||
| Progression to the G1b phase of the cell cycle is required for completion of human immunodeficiency virus type 1 reverse transcription in T cells | Q33783211 | ||
| Integration of murine leukemia virus DNA depends on mitosis | Q34051046 | ||
| Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector | Q36586077 | ||
| Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector | Q37251114 | ||
| Development of HIV vectors for anti-HIV gene therapy | Q37251477 | ||
| Nonproductive human immunodeficiency virus type 1 infection in nucleoside-treated G0 lymphocytes | Q39595263 | ||
| Moloney murine leukemia virus-derived retroviral vectors decay intracellularly with a half-life in the range of 5.5 to 7.5 hours | Q39881415 | ||
| Human immunodeficiency virus infection of cells arrested in the cell cycle | Q41531689 | ||
| Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors | Q43716886 | ||
| Hepatic gene therapy: persistent expression of human alpha 1-antitrypsin in mice after direct gene delivery in vivo | Q45879739 | ||
| L-histidinol provides effective selection of retrovirus-vector-transduced keratinocytes without impairing their proliferative potential | Q45880428 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 49-52 | |
| P577 | publication date | 2000-01-01 | |
| P1433 | published in | Nature Genetics | Q976454 |
| P1476 | title | Efficient lentiviral transduction of liver requires cell cycling in vivo | |
| P478 | volume | 24 |
| Q36906020 | 20-HETE mediates proliferation of renal epithelial cells in polycystic kidney disease |
| Q37078777 | 20-HETE-mediated cytotoxicity and apoptosis in ischemic kidney epithelial cells |
| Q44915884 | A lentiviral vector expressing a fusogenic glycoprotein for cancer gene therapy |
| Q39733540 | A new hybrid system capable of efficient lentiviral vector production and stable gene transfer mediated by a single helper-dependent adenoviral vector |
| Q34497332 | AAV-mediated gene transfer for hemophilia |
| Q34124149 | Activator of G protein signaling 3 promotes epithelial cell proliferation in PKD. |
| Q40394484 | Adeno-associated virus-mediated bone morphogenetic protein-7 gene transfer induces C2C12 cell differentiation into osteoblast lineage cells |
| Q34329754 | Advanced modular self-inactivating lentiviral expression vectors for multigene interventions in mammalian cells and in vivo transduction |
| Q41980779 | Altering α-dystroglycan receptor affinity of LCMV pseudotyped lentivirus yields unique cell and tissue tropism |
| Q44620413 | An in vivo transfection system for inducible gene expression and gene silencing in murine hepatocytes |
| Q93353440 | Antiangiogenic Gene Therapy in Cancer |
| Q40099387 | Assembly of hepatitis B virus envelope proteins onto a lentivirus pseudotype that infects primary human hepatocytes |
| Q38693642 | Assessment of selected media supplements to improve F/HN lentiviral vector production yields. |
| Q37176481 | Back to the future: a recent history of haemophilia treatment |
| Q33285871 | Centrosomal latency of incoming foamy viruses in resting cells |
| Q38472381 | Conditional expression of a suicide gene by the telomere reverse transcriptase promoter for potential post-therapeutic deletion of tumorigenesis |
| Q44631505 | Correction of Bleeding Diathesis Without Liver Toxicity Using Arenaviral-Pseudotyped HIV-1–Based Vectors in Hemophilia A Mice |
| Q37931159 | Countering hepatitis B virus infection using RNAi: how far are we from the clinic? |
| Q40197541 | Critical assessment of lifelong phenotype correction in hyperbilirubinemic Gunn rats after retroviral mediated gene transfer |
| Q33565275 | Delivery of factor VIII gene into skeletal muscle cells using lentiviral vector |
| Q34019566 | Design of an HIV-1 lentiviral-based gene-trap vector to detect developmentally regulated genes in mammalian cells |
| Q30453447 | Development of an avian leukosis-sarcoma virus subgroup A pseudotyped lentiviral vector |
| Q33787285 | Development of multigene and regulated lentivirus vectors |
| Q39292167 | Development of packaging cell lines for generation of adeno-associated virus vectors by lentiviral gene transfer of trans-complementary components |
| Q44223354 | Doxycycline-regulated lentiviral vector system with a novel reverse transactivator rtTA2S-M2 shows a tight control of gene expression in vitro and in vivo |
| Q35596574 | Effects of vector backbone and pseudotype on lentiviral vector-mediated gene transfer: studies in infant ADA-deficient mice and rhesus monkeys |
| Q45888555 | Efficient gene transduction to cultured hepatocytes by HIV-1 derived lentiviral vector |
| Q45878744 | Emerging and receding risks of therapeutic regimens for haemophilia |
| Q40619697 | Engineered long terminal repeats of retroviral vectors enhance transgene expression in hepatocytes in vitro and in vivo |
| Q28586805 | Enhanced erythropoiesis in Hfe-KO mice indicates a role for Hfe in the modulation of erythroid iron homeostasis |
| Q35149966 | Episomal persistence of recombinant adenoviral vector genomes during the cell cycle in vivo |
| Q37512409 | Ex vivo gene delivery to hepatocytes: techniques, challenges, and underlying mechanisms |
| Q35919263 | Expression of exogenetic enhanced green fluorescent protein in rat endocranium through lentivirus infection |
| Q43188456 | Expression of papillomavirus L1 proteins regulated by authentic gene codon usage is favoured in G2/M-like cells in differentiating keratinocytes |
| Q35904452 | Fetal and neonatal gene therapy: benefits and pitfalls |
| Q37594766 | Foamy virus vectors for gene transfer |
| Q45885518 | Gene and antisense delivery in alcoholism research |
| Q34530130 | Gene therapy for haemophilia. |
| Q34368127 | Gene therapy for haemophilia: the end of a 'royal pathology' in the third millennium? |
| Q64379985 | Gene therapy for hemophilia |
| Q45160558 | Gene therapy for hemophilia: are viral vectors really feasible? |
| Q45877159 | Gene therapy for hemophilia? Yes. |
| Q37346064 | Gene therapy for liver enzyme deficiencies: what have we learned from models for Crigler-Najjar and tyrosinemia? |
| Q34997896 | Gene therapy for the central nervous system in the lysosomal storage disorders |
| Q64377524 | Gene therapy for the hemophilias |
| Q35630146 | Gene therapy in orthopaedic surgery: the current status |
| Q35208038 | Gene therapy of hepatocarcinoma: a long way from the concept to the therapeutical impact |
| Q34176027 | Gene therapy: a 2001 perspective |
| Q34497310 | Gene therapy: a brief overview of the past, present, and future |
| Q34636968 | Gene therapy: reality or myth for the global bleeding disorders community? |
| Q36230845 | Gene transfer for hemophilia: can therapeutic efficacy in large animals be safely translated to patients? |
| Q34375860 | Genetic engineering within the adult brain: implications for molecular approaches to behavioral neuroscience |
| Q44845534 | Helper-Independent Sleeping Beauty transposon-transposase vectors for efficient nonviral gene delivery and persistent gene expression in vivo |
| Q35181577 | Hemophilia: treatment options in the twenty-first century |
| Q40639511 | Hepatoma cell-specific ganciclovir-mediated toxicity of a lentivirally transduced HSV-TkEGFP fusion protein gene placed under the control of rat alpha-fetoprotein gene regulatory sequences |
| Q37644966 | Heritable and inducible gene knockdown in astrocytes or neurons in vivo by a combined lentiviral and RNAi approach. |
| Q40740222 | High efficiency lentiviral gene delivery in non-dividing cells by deoxynucleoside treatment |
| Q73298912 | High efficiency protein transduction of quiescent and proliferating primary hematopoietic cells |
| Q35666730 | Home management of haemophilia. |
| Q38183539 | Hydrodynamic transfection for generation of novel mouse models for liver cancer research |
| Q35828547 | Identification of a novel TGF-β-miR-122-fibronectin 1/serum response factor signaling cascade and its implication in hepatic fibrogenesis. |
| Q36105888 | In utero gene therapy: current challenges and perspectives. |
| Q40132247 | In vitro and in vivo induction of bone formation based on adeno-associated virus-mediated BMP-7 gene therapy using human adipose-derived mesenchymal stem cells |
| Q34328596 | In vivo assessment of gene delivery to keratinocytes by lentiviral vectors |
| Q34344453 | In vivo gene transfer using a nonprimate lentiviral vector pseudotyped with Ross River Virus glycoproteins |
| Q33691863 | In vivo stable transduction of humanized liver tissue in chimeric mice via high-capacity adenovirus-lentivirus hybrid vector |
| Q44057415 | Intravenous administration of an E1/E3-deleted adenoviral vector induces tolerance to factor IX in C57BL/6 mice |
| Q40322398 | Jaagsiekte sheep retrovirus pseudotyped lentiviral vector-mediated gene transfer to fetal ovine lung |
| Q52172176 | Learning from lentiviruses. |
| Q35231284 | Lentiviral gene transfer into the dorsal root ganglion of adult rats |
| Q35865275 | Lentiviral vector design using alternative RNA export elements |
| Q73121677 | Lentiviral vectors |
| Q43954074 | Lentiviral vectors for efficient transduction of isolated primary quiescent hepatocytes |
| Q39593815 | Lentivirus gene transfer in murine hematopoietic progenitor cells is compromised by a delay in proviral integration and results in transduction mosaicism and heterogeneous gene expression in progeny cells |
| Q35149980 | Lentivirus vectors incorporating the immunoglobulin heavy chain enhancer and matrix attachment regions provide position-independent expression in B lymphocytes |
| Q42097990 | Lentivirus-mediated transgene delivery to the hippocampus reveals sub-field specific differences in expression. |
| Q35904443 | Liver gene therapy: advances and hurdles |
| Q35788586 | Liver repopulation by Bcl-x(L) transgenic hepatocytes |
| Q35989150 | Long-term correction of diabetes in rats after lentiviral hepatic insulin gene therapy |
| Q44848775 | Long-term lowering of plasma cholesterol levels in LDL-receptor-deficient WHHL rabbits by gene therapy |
| Q44536266 | Long-term transgene expression by administration of a lentivirus-based vector to the fetal circulation of immuno-competent mice. |
| Q35003246 | Loss of activator of G-protein signaling 3 impairs renal tubular regeneration following acute kidney injury in rodents |
| Q55428320 | MicroRNA-125b Promotes Hepatic Stellate Cell Activation and Liver Fibrosis by Activating RhoA Signaling. |
| Q33576396 | Microporation is a valuable transfection method for efficient gene delivery into human umbilical cord blood-derived mesenchymal stem cells |
| Q34269646 | Molecular therapeutics of liver disease |
| Q37176506 | New assays for monitoring haemophilia treatment |
| Q43477694 | Newborn liver gene transfer by an HIV-2-based lentiviral vector. |
| Q44815512 | Non-invasive viral gene transfer of factor IX to colonic epithelial cells in hemophilia B mice |
| Q37061714 | Nonhomologous-End-Joining Factors Regulate DNA Repair Fidelity during Sleeping Beauty Element Transposition in Mammalian Cells |
| Q33802664 | Nonrandom transduction of recombinant adeno-associated virus vectors in mouse hepatocytes in vivo: cell cycling does not influence hepatocyte transduction |
| Q38905682 | Novel lentiviral-inducible transgene expression systems and versatile single-plasmid reporters for in vitro and in vivo cancer biology studies |
| Q45880348 | Organ distribution of gene expression after intravenous infusion of targeted and untargeted lentiviral vectors. |
| Q42261436 | Osteogenic differentiation of human periodontal ligament cells after transfection with recombinant lentiviral vector containing follicular dendritic cell secreted protein |
| Q42846730 | Partial attenuation of cytotoxicity and apoptosis by SOD1 in ischemic renal epithelial cells |
| Q34609626 | Parvovirus-mediated gene transfer for the haemophilias |
| Q42199346 | Polyploidization without mitosis improves in vivo liver transduction with lentiviral vectors |
| Q35915704 | Preclinical and clinical gene therapy for haemophilia |
| Q42424129 | Priming of hepatocytes enhances in vivo liver transduction with lentiviral vectors in adult mice |
| Q43830772 | Production of human clotting Factor IX without toxicity in mice after vascular delivery of a lentiviral vector |
| Q35120176 | Progress and problems with the use of viral vectors for gene therapy |
| Q34354549 | Proline residues within spacer peptide p1 are important for human immunodeficiency virus type 1 infectivity, protein processing, and genomic RNA dimer stability |
| Q40221155 | Prolonged adherence of human immunodeficiency virus-derived vector particles to hematopoietic target cells leads to secondary transduction in vitro and in vivo |
| Q37678176 | Recent advances in lentiviral vector development and applications |
| Q45861906 | Repopulation of rat liver by fetal hepatoblasts and adult hepatocytes transduced ex vivo with lentiviral vectors |
| Q41866974 | Reversal of diabetes through gene therapy of diabetic rats by hepatic insulin expression via lentiviral transduction |
| Q34515859 | Slipping through the door: HIV entry into the nucleus |
| Q41734970 | Somatic integration and long-term transgene expression in normal and haemophilic mice using a DNA transposon system |
| Q45873385 | Specific detection of human coagulation factor IX in cynomolgus macaques |
| Q37001594 | Staunch protections: the ethics of haemophilia gene transfer research |
| Q44966515 | Successful lentivirus-based delivery of NLS-LACZ gene into porcine hepatocytes |
| Q42819436 | Suppression of 11beta-hydroxysteroid dehydrogenase type 1 with RNA interference substantially attenuates 3T3-L1 adipogenesis |
| Q45875852 | Sustained and therapeutic delivery of factor IX in nude haemophilia B mice by encapsulated C2C12 myoblasts: concurrent tumourigenesis. |
| Q41691498 | Sustained inhibition of hepatitis B virus replication in vivo using RNAi-activating lentiviruses |
| Q45855463 | Targeting vascular injury using Hantavirus-pseudotyped lentiviral vectors |
| Q45876374 | The Genetics of bleeding disorders: a report on the UK Haemophilia Centre Doctors' Organisation annual scientific symposium, 10th October 2003. |
| Q45863921 | The P-selectin cytoplasmic domain directs the cellular storage of a recombinant chimeric factor IX. |
| Q53652323 | The effect of age on hepatic gene transfer with self-inactivating lentiviral vectors in vivo. |
| Q36890651 | The intermediate conductance calcium-activated potassium channel KCa3.1 regulates vascular smooth muscle cell proliferation via controlling calcium-dependent signaling |
| Q45855320 | The measurement of low levels of factor VIII or factor IX in hemophilia A and hemophilia B plasma by clot waveform analysis and thrombin generation assay |
| Q34364782 | Transduction of interphase cells by avian sarcoma virus. |
| Q44519606 | Transplantation of murine bone marrow stromal cells under the kidney capsule to secrete coagulation factor VIII. |
| Q28141424 | Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics |
Search more.